Skip to main content
. 2019 Mar 15;14(3):e0213746. doi: 10.1371/journal.pone.0213746

Table 2. Test strategy (N = 460).

Strategy Genes tested No. (%)
Predictive Testing (Single site mutation analysis) (n = 41) BRCA1 24 (57.1)
BRCA2 15 (35.7)
BRCA2 and RET 2 (4.8)
Targeted Testing (n = 156) BRCA1/2 149 (95.5)
BRCA1/2 and Mismatch Repair Genes 6 (3.8)
BRCA1/2 and PTEN 1 (0.6)
Panel-based Testing (n = 263) 14-gene panel 2 (0.8)
29-gene panel 32 (12.2)
34-gene panel 83 (31.6)
49-gene panel 146 (55.5)